Brain volume dynamics in multiple sclerosis. A case-control study

References

• Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338(5):278–285.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Nousia A, Siokas V, et al. Efficacy of computer-based cognitive training in neuropsychological performance of patients with multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord. 2017 Dec;24(20):58–66.
   Google Scholar
• Sokratous M, Dardiotis E, Tsouris Z, et al. Deciphering the role of DNA methylation in multiple sclerosis: emerging issues. Auto Immun Highlights. 2016 Dec;7(1):12.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Panayiotou E, Siokas V, et al. Gene variants of adhesion molecules predispose to MS: a case-control study. Neurol Genet. 2019 Feb;5(1):e304.
   PubMed Web of Science ®Google Scholar
• Hadjigeorgiou GM, Kountra PM, Koutsis G, et al. Replication study of GWAS risk loci in Greek multiple sclerosis patients. Neurol Sci. 2019 Feb;40(2):253–260.
   Google Scholar
• Sokratous M, Dardiotis E, Bellou E, et al. CpG island methylation patterns in relapsing-remitting multiple sclerosis. J Mol Neurosci. 2018 Mar 7;64:478–484.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Tsouris Z, Aslanidou P, et al. Body mass index in patients with multiple sclerosis: a meta-analysis. Neurol Res. 2019;31:1–11.
   Google Scholar
• Rovaris M, Filippi M. Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis. Curr Opin Neurol. 1999;12(3):337–344.
   PubMed Web of Science ®Google Scholar
• Fisniku LK, Chard DT, Jackson JS, et al. Gray matter atrophy is related to long‐term disability in multiple sclerosis. Ann Neurol. 2008;64(3):247–254.
   PubMed Web of Science ®Google Scholar
• Messina S, Patti F. Gray matters in multiple sclerosis: cognitive impairment and structural MRI. Mult Scler Int. 2014;2014:1–9.
   PubMedGoogle Scholar
• Horakova D, Dwyer MG, Havrdova E, et al. Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis: a 5-year longitudinal study. J Neurol Sci. 2009;282(1–2):112–119.
   PubMed Web of Science ®Google Scholar
• Calabrese M, Rinaldi F, Poretto V, et al. The puzzle of multiple sclerosis: gray matter finds its place. Expert Rev Neurother. 2011;11(11):1565–1568.
   PubMed Web of Science ®Google Scholar
• Schoonheim MM, Popescu V, Lopes FCR, et al. Subcortical atrophy and cognition sex effects in multiple sclerosis. Neurology. 2012;79(17):1754–1761.
   PubMed Web of Science ®Google Scholar
• Debernard L, Melzer TR, Alla S, et al. Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis. Psychiatry Res Neuroim. 2015;234(3):352–361.
   Web of Science ®Google Scholar
• Rocca MA, Parisi L, Pagani E, et al. Regional but not global brain damage contributes to fatigue in multiple sclerosis. Radiology. 2014;273(2):511–520.
   PubMed Web of Science ®Google Scholar
• Mesaros S, Rocca MA, Sormani MP, et al. Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS. J Neurol. 2008;255(9):1378–1383.
   PubMed Web of Science ®Google Scholar
• Vollmer T, Signorovitch J, Huynh L, et al. The natural history of brain volume loss among patients with multiple sclerosis: a systematic literature review and meta-analysis. J Neurol Sci. 2015;357(1–2):8–18.
   PubMed Web of Science ®Google Scholar
• Chu R, Kim G, Tauhid S, et al. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines. PloS One. 2018;13(11):e0206939.
   PubMed Web of Science ®Google Scholar
• Koubiyr I, Deloire M, Coupe P, et al. Differential gray matter vulnerability in the 1 year following a clinically isolated syndrome. Front Neurol. 2018;9:824.
   PubMed Web of Science ®Google Scholar
• Rojas J, Sánchez F, Patrucco L, et al. Brain structural changes in patients in the early stages of multiple sclerosis with depression. Neurol Res. 2017;39(7):596–600.
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162–173.
   Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444.
   PubMed Web of Science ®Google Scholar
• Neacsu V, Jasperse B, Korteweg T, et al. Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA. J Magn Reson Imaging. 2008;28(3):559–565.
   PubMed Web of Science ®Google Scholar
• Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17(3):143–155.
   PubMed Web of Science ®Google Scholar
• Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23:S208–S219.
   PubMed Web of Science ®Google Scholar
• Jenkinson M, Bannister P, Brady M, et al. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17(2):825–841.
   PubMed Web of Science ®Google Scholar
• Patenaude B, Smith SM, Kennedy DN, et al. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage. 2011;56(3):907–922.
   PubMed Web of Science ®Google Scholar
• Smith SM, De Stefano N, Jenkinson M, et al. Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr. 2001;25(3):466–475.
   PubMed Web of Science ®Google Scholar
• Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 2002;17(1):479–489.
   PubMed Web of Science ®Google Scholar
• Durand-Dubief F, Belaroussi B, Armspach J, et al. Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques. Am J Neuroradiol. 2012;33:1918–1924.
   Web of Science ®Google Scholar
• De Stefano N, Stromillo ML, Giorgio A, et al. Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2016;87(1):93–99.
   PubMed Web of Science ®Google Scholar
• Bergsland N, Horakova D, Dwyer M, et al. Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Am J Neuroradiol. 2012;33:1573–1578.
   Web of Science ®Google Scholar
• Bishop CA, Newbould RD, Lee JS, et al. Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions. NeuroImage Clin. 2017;13:9–15.
   PubMed Web of Science ®Google Scholar
• Modica CM, Bergsland N, Dwyer MG, et al. Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis. Mult Scler J. 2016;22(1):36–42.
   PubMed Web of Science ®Google Scholar
• Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain. 2002;125(8):1676–1695.
   PubMed Web of Science ®Google Scholar
• De Stefano N, Giorgio A, Battaglini M, et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology. 2010;74(23):1868–1876.
   PubMed Web of Science ®Google Scholar
• Kalkers NF, Ameziane N, Bot JC, et al. Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. Arch Neurol. 2002;59(10):1572–1576.
   PubMedGoogle Scholar
• Anderson VM, Fox NC, Miller DH. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging. 2006;23(5):605–618.
   PubMed Web of Science ®Google Scholar
• Zivadinov R, Bakshi R. Central nervous system atrophy and clinical status in multiple sclerosis. J Neuroimaging. 2004;14:27S–35S.
   PubMed Web of Science ®Google Scholar
• Jacobsen C, Hagemeier J, Myhr KM, et al. Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study. J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1109–1115.
   PubMed Web of Science ®Google Scholar
• Rojas JI, Patrucco L, Besada C, et al. Brain atrophy at onset and physical disability in multiple sclerosis. Arq Neuropsiquiatr. 2012;70(10):765–768.
   PubMed Web of Science ®Google Scholar
• Sormani MP, Arnold DL, De Stefano N. Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis. Ann Neurol. 2014;75(1):43–49.
   PubMed Web of Science ®Google Scholar
• Hofstetter L, Naegelin Y, Filli L, et al. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis. Mult Scler. 2014 Feb;20(2):202–213.
   PubMed Web of Science ®Google Scholar